Cetrorelix
Precisely controls hormone timing during fertility treatment, preventing premature ovulation.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- cetrorelix acetate (GnRH antagonist)
- Brand Names
- Cetrotide
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Reproductive Health
- Prescribing Specialties
- Reproductive endocrinology, OB-GYN
What it does
Cetrorelix is an FDA-approved medication that your doctor can prescribe. GnRH antagonist that competitively blocks GnRH receptors on pituitary gonadotroph cells, rapidly suppressing LH and FSH release to prevent premature ovulation.
How it's taken
Daily subcutaneous injection (short course during fertility treatment)
How people access it
Prescribed by reproductive endocrinologists as part of IVF protocols. Administered during a short treatment window.
What doctors prescribe it for
- Inhibition of premature LH surges in women undergoing controlled ovarian stimulation for assisted reproduction
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Cetrorelix through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Cetrotide to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Cetrorelix (Cetrotide) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Cetrorelix is FDA-approved for: Inhibition of premature LH surges in women undergoing controlled ovarian stimulation for assisted reproduction. Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Cetrorelix through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Cetrorelix compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides